Hisun Biologics Unit was established in 2003, employs over 600 technical personnel with expertise in developing and manufacturing of complex generic formulation and innovative biological drugs. Our state-of-the-art facilities, produce a diverse pipeline of products, including monoclonal antibodies, recombinant and fusion proteins, peptides, cell factors, vaccines, and antibody drug conjugations.

No. Product Expression System Indicatioin
1 Adalimumab CHO cell RA, AS
2 anti-CD20 Mab (Rituximab Bio-better) CHO cell Oncology
3 Denosumab CHO cell Oncology
4 Etanercept CHO cell RA, AS, Psoriasis
5 Infliximab CHO cell RA, IBD
6 Insulin Aspart E.coli Diabetes
7 Insulin Glargine E.coli Diabetes
8 Pertuzumab CHO cell Oncology
9 Recombinant Human Insulin E.coli Diabetes
10 Recombinant Interleukin -1Ra E.coli RA
11 Trastuzumab CHO cell Oncology
12 Tocilizumab CHO cell RA